SMS Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE812G01025
  • NSEID: SMSPHARMA
  • BSEID: 532815
INR
473.65
-8.7 (-1.8%)
BSENSE

Nov 20

BSE+NSE Vol: 2.06 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 517655,
    "name": "SMS Pharma.",
    "stock_name": "SMS Pharma.",
    "full_name": "SMS Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/sms-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "473.65",
    "chg": -8.7,
    "chgp": "-1.8%",
    "dir": -1,
    "prev_price": "482.35",
    "mcapval": "4,467.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532815,
    "symbol": "SMSPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE812G01025",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "2.06 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/sms-pharma-517655-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "SMS Pharmaceuticals Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4263747",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SMSPharmaceutic_mojoScore_4263747.png",
        "date": "2026-11-16 10:10:35",
        "description": "SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 November 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "SMS Pharmaceuticals Falls 2.55% Despite Technical Gains: 5 Key Factors Driving the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sms-pharmaceuticals-falls-255-despite-technical-gains-5-key-factors-driving-the-week-4255805",
        "imagepath": "",
        "date": "2026-11-07 17:04:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 2:</strong> Stock opens at ₹504.25, down 1.47% amid mixed technical momentum</p>\n                    <p><strong>Nov 3:</strong> Technical momentum shifts mildly bullish; stock rebounds to ₹513.70 (+1.87%)</p>\n                    <p><strong>Nov 4:</strong> SMS Pharmaceuticals hits new 52-week and all-time highs near ₹524.95; bullish technical upgrades</p>\n                    <p><strong>Nov 5:</strong> Quarterly results reveal strong turnaround; stock dips 1.99% to ₹515.95</p>\n                    <p><strong>Nov 6:</strong> Profit-taking intensifies; stock closes at ₹498.70 (-3.34%) despite Sensex gains</p>\n                </div>\n\n                <div class=\"stats-row\">\n         ..."
      },
      {
        "title": "SMS Pharmaceuticals Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4252185",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SMSPharmaceutic_mojoScore_4252185.png",
        "date": "2026-11-05 10:10:03",
        "description": "SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 November 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Reports Strong Quarterly Turnaround with Robust Revenue and Margin Expansion",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sms-pharmaceuticals-ltd-reports-strong-quarterly-turnaround-with-robust-revenue-and-margin-expansion-4251097",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SMSPharmaceutic_fintrenddot_4251097.png",
        "date": "2026-11-05 08:00:26",
        "description": "SMS Pharmaceuticals Ltd has demonstrated a remarkable turnaround in its financial performance for the quarter ended September 2026, registering record highs across key metrics and prompting an upgrade in its market rating from Sell to Hold. This shift reflects a very positive financial trend, signalling renewed investor confidence in the small-cap pharmaceutical player amid a challenging industry backdrop."
      },
      {
        "title": "Broad-Based Technical Strength Lifts SMS Pharmaceuticals Ltd to 52-Week High of Rs 524.95",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sms-pharmaceuticals-ltd-hits-new-52-week-high-marking-significant-rally-4250866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SMSPharmaceutic_priceRelatedfactors_4250866.png",
        "date": "2026-11-04 13:10:10",
        "description": "With a remarkable 85.5% gain over the past year, SMS Pharmaceuticals Ltd has surged to a fresh 52-week high of Rs 524.95 on 4 Nov 2026, significantly outperforming the Sensex which declined by 7.72% over the same period. This milestone caps a sustained rally fuelled by strong technical momentum and a favourable market backdrop."
      },
      {
        "title": "Strong Momentum Meets Stretched Valuations as SMS Pharmaceuticals Ltd Reaches All-Time High",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sms-pharmaceuticals-ltd-hits-all-time-high-amid-strong-market-momentum-4250864",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SMSPharmaceutic_priceRelatedfactors_4250864.png",
        "date": "2026-11-04 13:05:36",
        "description": ""
      },
      {
        "title": "SMS Pharmaceuticals Ltd Sees Bullish Momentum Amid Technical Upgrades",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sms-pharmaceuticals-ltd-sees-bullish-momentum-amid-technical-upgrades-4249856",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SMSPharmaceutic_technicaldot_4249856.png",
        "date": "2026-11-04 08:02:53",
        "description": "SMS Pharmaceuticals Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from a mildly bullish to a bullish trend. This change is underscored by robust weekly and monthly MACD and Bollinger Bands readings, alongside daily moving averages confirming upward momentum, positioning the small-cap pharmaceutical player for potential further gains."
      },
      {
        "title": "SMS Pharmaceuticals Surges 23.40% in a Week: 6 Key Drivers Behind the Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sms-pharmaceuticals-surges-2340-in-a-week-6-key-drivers-behind-the-rally-4246073",
        "imagepath": "",
        "date": "2026-10-31 17:02:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Technical momentum shifts to mildly bullish</p>\n                    <p><strong>27 Oct:</strong> Momentum upgrades to bullish with strong long-term returns</p>\n                    <p><strong>28 Oct:</strong> Intraday high surge of 7.63% amid market weakness</p>\n                    <p><strong>30 Oct:</strong> New 52-week and all-time high at Rs.499.40 and intraday peak of Rs.520</p>\n                    <p><strong>30 Oct:</strong> Week closes at Rs.511.75, +23.40% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                 ..."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Surges 7.73% to Day's High of Rs 520 — Outperforms Sector by 6.09 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sms-pharmaceuticals-ltd-hits-intraday-high-with-773-surge-on-30-oct-2026-4244853",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SMSPharmaceutic_priceRelatedfactors_4244853.png",
        "date": "2026-10-30 11:02:04",
        "description": "The Sensex edged up 0.15% on 30 Oct 2026, while SMS Pharmaceuticals Ltd surged 7.73%, marking a standout session with a 6.09 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp intraday gain rewrites the short-term narrative for the small-cap stock, which also hit a new 52-week and all-time high of Rs 520 during the session."
      }
    ],
    "total": 90,
    "sid": "517655",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/sms-pharmaceuticals-517655"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "10-Nov-2026",
      "details": "Earnings Call Transcript",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "05-Nov-2026",
      "details": "Investors Meet Audio Recording",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "05-Nov-2026",
      "details": "Newspaper cutting of published financial results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "SMS Pharmaceuticals Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Sep 26",
          "dt": "2026-09-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "SMS Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 17 Dec 15",
          "dt": "2015-12-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

10-Nov-2026 | Source : BSE

Earnings Call Transcript

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

05-Nov-2026 | Source : BSE

Investors Meet Audio Recording

Announcement under Regulation 30 (LODR)-Newspaper Publication

05-Nov-2026 | Source : BSE

Newspaper cutting of published financial results

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

SMS Pharmaceuticals Ltd has declared 40% dividend, ex-date: 22 Sep 26

stock-summary
SPLITS

SMS Pharmaceuticals Ltd has announced 1:10 stock split, ex-date: 17 Dec 15

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available